Sarcomas arising after radiotherapy for peptic ulcer disease.
Therapeutic gastric irradiation has been used to reduce peptic juice secretion in patients with peptic ulcer disease. Between 1937 and 1968 a total of 2049 patients received such therapy at the University of Chicago. Three of these patients are known to have developed sarcomas in the field of radiation. Two gastric leiomyosarcomas of the stomach were diagnosed 26 and 14 years after treatment and a malignant fibrous histiocytoma of the anterior chest wall was removed six years after gastric irradiation. Of 743 peptic ulcer patients treated without irradiation and constituted as a control group for the study of therapeutic gastric radiation, none is known to have developed sarcoma. As the incidence of sarcoma in these patient groups is known only from the tumor registry of the University of Chicago, other cases of sarcoma may exist in the groups. While an increased incidence of sarcoma has not been proven to occur in patients who received therapeutic gastric irradiation for peptic ulcer disease, the possibility of such a risk should be borne in mind by physicians caring for such patients.
Lieber
M R
MR
Winans
C S
CS
Griem
M L
ML
Moossa
R
R
Elner
V M
VM
Franklin
W A
WA
D000328:Adult; D000368:Aged; D005260:Female; D018219:Histiocytoma, Benign Fibrous / Q000209:etiology / Q000473:pathology; D006801:Humans; D007890:Leiomyosarcoma / Q000209:etiology* / Q000473:pathology; D008297:Male; D008875:Middle Aged; D009381:Neoplasms, Radiation-Induced / Q000209:etiology* / Q000473:pathology; D010437:Peptic Ulcer / Q000532:radiotherapy*; D011878:Radiotherapy / Q000009:adverse effects*; D013274:Stomach Neoplasms / Q000209:etiology* / Q000473:pathology; D013899:Thoracic Neoplasms / Q000209:etiology / Q000473:pathology